Edwards Lifesciences (NYSE: EW) shares are rallying Friday after the company’s EVOQUE tricuspid valve replacement system was approved by the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE